Hi! Did you know that you can easily reorder a previous order on My Pages? Just click “reorder” to get all your favourites delivered again.
Dr. Marina Murphy is one of the authors of the paper “Why We Need Greater, Not Less, Access to Reduced-Risk Nicotine Products”, published in the Cureus Journal of Medical Science. Haypp have met with her to get a better understanding of her message to smokers and policymakers.
"Our motivation was simple: too often policy is made with idealised assumptions that ignore how real people behave.
We have seen several cases where reducing or shutting off access to lower-risk products has resulted in people reverting to cigarettes — the status quo. We wanted to make the case that harm reduction requires more choices and more support, not fewer options."
"The greatest risk is that bans will push consumers into illicit or unregulated channels, where safety, quality, and age control are far weaker or just non-existent.
Bans also disproportionately hurt people in rural or remote areas, or those with mobility or access constraints, for whom online purchasing is essential."
"I strongly advocate for innovation in compliance — better digital age verification, identity checks, fraud detection, and enforcement of existing laws.
We should also invest in education, retailer licensing, and penalties for illegal sales. The goal should be to secure the online channel, not shut it down."
"Yes — in Australia, restricting e-cigarettes to prescription-only status has reportedly slowed progress in reducing combustible smoking and elevated black-market sales.
That experience underlines how restrictive approaches can undermine, rather than accelerate, public health gains."
"To smokers: safer alternatives deserve consideration, and policy should not erect needless barriers. To policymakers: embrace a nuanced, pragmatic harm-reduction strategy — regulate smartly, not restrict blindly.
Adult consumers deserve access to better options, especially if we hope to reduce smoking’s health toll."
Read Dr. Murphy's article “Why We Need Greater, Not Less, Access to Reduced-Risk Nicotine Products” here.